| |
| |
|
| Insider
Information: |
Von Rickenbach Josef H |
| Relationship: |
FORMER DIRECTOR |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
570,460 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,383,550 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
570,460 |
|
|
| Total
Value |
$3,383,550 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 41.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PAREXEL International |
PRXL |
Chairman & CEO, Director |
2017-09-29 |
0 |
2003-08-21 |
0 |
Premium* |
|
|
Aileron Therapeutics Inc |
ALRN |
Director |
2020-06-08 |
445,460 |
|
0 |
Premium* |
|
|
Virgin Orbit Holdings, Inc |
VORB |
FORMER DIRECTOR |
2021-12-29 |
125,000 |
2021-12-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VORB |
Virgin Orbit Holdings, In... |
FORMER DIRECTOR |
– – – |
2021-12-29 |
4 |
A |
$10.00 |
$1,250,000 |
D/D |
125,000 |
125,000 |
0 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2020-06-08 |
4 |
B |
$1.10 |
$249,999 |
D/D |
227,272 |
445,460 |
2.39 |
% |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2019-09-13 |
4 |
B |
$0.97 |
$24,255 |
D/D |
25,000 |
218,188 |
2.39 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2019-09-12 |
4 |
B |
$0.98 |
$86,250 |
D/D |
88,145 |
193,188 |
2.39 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2019-09-04 |
4 |
B |
$0.71 |
$16,583 |
D/D |
23,225 |
105,043 |
2.39 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2019-09-03 |
4 |
B |
$0.70 |
$9,428 |
D/D |
13,466 |
81,818 |
2.39 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2019-08-30 |
4 |
B |
$0.73 |
$10,968 |
D/D |
15,000 |
68,352 |
2.39 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2019-08-29 |
4 |
B |
$0.77 |
$2,771 |
D/D |
3,600 |
53,352 |
2.31 |
- |
|
| ALRN |
Aileron Therapeutics Inc |
Director |
– • – |
2019-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
49,752 |
|
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2017-09-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(503,329) |
0 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2017-09-14 |
4 |
D |
$87.93 |
$408,171 |
D/D |
(4,642) |
503,329 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2017-09-11 |
4 |
D |
$87.77 |
$1,351,834 |
D/D |
(15,402) |
507,971 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2017-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,308 |
523,373 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2017-09-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
22,795 |
514,065 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2016-09-14 |
4 |
A |
$0.00 |
$0 |
D/D |
29,600 |
536,353 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2016-09-12 |
4 |
D |
$66.54 |
$980,999 |
D/D |
(14,743) |
506,753 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2015-09-21 |
4 |
D |
$72.10 |
$1,938,336 |
D/D |
(26,884) |
521,130 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2015-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
21,015 |
548,014 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2015-03-06 |
5 |
GD |
$0.00 |
$0 |
D/D |
15,400 |
526,999 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2015-02-13 |
4 |
OE |
$20.26 |
$4,547,621 |
D/D |
172,575 |
724,381 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2015-02-13 |
4 |
D |
$63.09 |
$7,387,713 |
D/D |
(117,098) |
607,283 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2015-02-13 |
4 |
S |
$62.49 |
$4,070,641 |
D/D |
(65,100) |
542,183 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2014-09-22 |
4 |
D |
$61.38 |
$2,184,330 |
D/D |
(35,587) |
551,566 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2014-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
24,200 |
587,153 |
0 |
- |
|
| PRXL |
PAREXEL International |
Chairman & CEO |
• • – |
2014-02-10 |
4 |
S |
$49.76 |
$2,488,000 |
D/D |
(50,000) |
562,641 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
